Clinical characteristics of Philadelphia positive T ‐cell lymphoid leukemias—(De novo and blast phase CML)
(Source: American Journal of Hematology)
Source: American Journal of Hematology - November 17, 2016 Category: Hematology Authors: Preetesh Jain, Hagop Kantarjian, Elias Jabbour, Rashmi Kanagal ‐Shamanna, Keyur Patel, Sherry Pierce, Guillermo Garcia‐Manero, Gautam Borthakur, Farhad Ravandi, Susan O'Brien, Jorge Cortes Tags: Correspondence Source Type: research

Concurrent STAT3, DNMT3A, and TET2 mutations in T ‐LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential
(Source: American Journal of Hematology)
Source: American Journal of Hematology - November 17, 2016 Category: Hematology Authors: Philipp W. Raess, Michael J. Cascio, Guang Fan, Richard Press, Brian J. Druker, Diana Brewer, Stephen E. Spurgeon Tags: Correspondence Source Type: research

Ixazomib Cardiotoxicity: A Possible Class Effect of Proteasome Inhibitors
(Source: American Journal of Hematology)
Source: American Journal of Hematology - November 16, 2016 Category: Hematology Authors: Hayan Jouni, Mary C. Aubry, Martha Q. Lacy, S. Vincent Rajkumar, Shaji K. Kumar, Robert L. Frye, Joerg Herrmann Tags: Diagnostic Imaging in Hematology Source Type: research

Encapsulated relapsed FLT3+AML (myeloid sarcoma) and H ürthle cell adenoma presenting in composite: Unlikely partners
(Source: American Journal of Hematology)
Source: American Journal of Hematology - November 15, 2016 Category: Hematology Authors: Fiona He, Kevin Ha, Zuzan Cayci, Maria Evasovich Swenson, Luiza Caramori, Khalid Amin, Michael A. Linden, Celalettin Ustun Tags: Correspondence Source Type: research

Primary myelofibrosis: 2017 update on diagnosis, risk ‐stratification, and management
Disease overview: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell‐derived clonal myeloproliferation that is often but not always accompanied by JAK2, CALR or MPL mutation, abnormal cytokine expression, bone marrow fibrosis, anemia, splenomegaly, extramedullary hematopoiesis (EMH), constitutional symptoms, cachexia, leukemic progression and shortened survival. Diagnosis: Diagnosis is based on bone marrow morphology. The presence of JAK2, CALR or MPL mutation is supportive but not essential for diagnosis; approximately 90% of patients carry one of these mutations and 10% are &l...
Source: American Journal of Hematology - November 15, 2016 Category: Hematology Authors: Ayalew Tefferi Tags: CME Information: Primary myelofibrosis: 2017 update on diagnosis, risk ‐stratification and management Source Type: research

Issue Information – Table of Contents
(Source: American Journal of Hematology)
Source: American Journal of Hematology - November 15, 2016 Category: Hematology Tags: Issue Information – Table of Contents Source Type: research

CD38, BCL ‐2, PD‐1, and PD‐1L expression in nodal peripheral T‐cell lymphoma: Possible biomarkers for novel targeted therapies?
(Source: American Journal of Hematology)
Source: American Journal of Hematology - November 9, 2016 Category: Hematology Authors: Francesco Zaja, Valentina Tabanelli, Claudio Agostinelli, Angelica Calleri, Annalisa Chiappella, Marzia Varettoni, Pier Luigi Zinzani, Stefano Volpetti, Elena Sabattini, Renato Fanin, Stefano A. Pileri Tags: Correspondence Source Type: research

Synchronous Presentation of Intra ‐nodal Follicular Dendritic Cell Sarcoma and Castleman Disease
(Source: American Journal of Hematology)
Source: American Journal of Hematology - November 7, 2016 Category: Hematology Authors: Preetesh Jain, Victor G. Prieto, John T. Manning, Nathan Fowler, L. Jeffrey Medeiros, Rashmi Kanagal ‐Shamanna Tags: Images in Hematology Source Type: research

Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patients
(Source: American Journal of Hematology)
Source: American Journal of Hematology - November 3, 2016 Category: Hematology Authors: John C. Reneau, Dennis Asante, Holly Van Houten, Lindsey R. Sangaralingham, Francis K. Buadi, Amir Lerman, Joerg Herrmann Tags: Correspondence Source Type: research

Validation of a Clinical Assay of Multi ‐Locus DNA Methylation for Prognosis of Newly Diagnosed AML
(Source: American Journal of Hematology)
Source: American Journal of Hematology - November 1, 2016 Category: Hematology Authors: Courtney D. DiNardo, Marlise R. Luskin, Martin Carroll, Catherine Smith, Jenna Harrison, Sherry Pierce, Steve Kornblau, Marina Konopleva, Tapan Kadia, Hagop Kantarjian, Gerald B. Wertheim, Stephen R. Master Tags: Correspondence Source Type: research

The Role of Acuity of Illness at Presentation in Early Mortality in Black Children with Acute Myeloid Leukemia
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - October 31, 2016 Category: Hematology Authors: Lena E. Winestone, Kelly D. Getz, Tamara P. Miller, Jennifer J. Wilkes, Leah Sack, Yimei Li, Yuan ‐Shung Huang, Alix E. Seif, Rochelle Bagatell, Brian T. Fisher, Andrew Epstein, Richard Aplenc Tags: Research Article Source Type: research

Early leukemic transformation of adult T ‐cell leukemia/lymphoma presenting as meningeal lymphoma
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 31, 2016 Category: Hematology Authors: Barbara J. Bain Tags: Morphology Update Source Type: research

Long ‐term outcome of NPM1 mutated acute myeloid leukemia: A single‐institution experience
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 31, 2016 Category: Hematology Authors: Hamid Sayar, Parvaneh Bashardoust, Larry Cripe, Sujata Chakraborty, Shaochun Bai Tags: Correspondence Source Type: research

Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease
In conclusion, pulmonary and cardiac impairment are associated with, and contribute to mortality in SCD. Therapies aimed at improving reduced FEV1%predicted and elevated TRJV could improve survival in patients with SCD. This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - October 31, 2016 Category: Hematology Authors: Shruti Chaturvedi, Djamila Labib Ghafuri, Adetola Kassim, Mark Rodeghier, Michael R. DeBaun Tags: Research Article Source Type: research

Progressive refractory Light Chain Amyloidosis and Multiple Myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - October 31, 2016 Category: Hematology Authors: Adir Shaulov, Chezi Ganzel, Noam Benyamini, Yossef Barshay, Neta Goldschmidt, David Lavie, Diana Libster, Alex Gural, Batia Avni, Moshe E. Gatt Tags: Research Article Source Type: research

Thrombotic Issues in Transgender Medicine: A Review
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - October 25, 2016 Category: Hematology Authors: Joseph J. Shatzel, Kara J Connelly, Thomas G. DeLoughery Tags: Critical Review Source Type: research

Management of Anemia in Patients with Congestive Heart Failure
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - October 24, 2016 Category: Hematology Authors: Lawrence Tim Goodnough, Josep Comin ‐Colet, Santiago Leal‐Noval, Sherri Ozawa, Jacqueline Takere, David Henry, Mazyar Javidroozi, Benjamin Hohmuth, Elvira Bisbe, Irwin Gross, Aryeh Shander Tags: Critical Review Source Type: research

Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphoma
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 24, 2016 Category: Hematology Authors: Hui Yu, Elena Sotillo, Colleen Harrington, Gerald Wertheim, Michele Paessler, Shannon L Maude, Susan R Rheingold, Stephan A Grupp, Andrei Thomas ‐Tikhonenko, Vinodh Pillai Tags: Correspondence Source Type: research

Effects of Hydroxyurea on F ‐cells in Sickle Cell Disease and Potential Impact of a Second Fetal Globin Inducer
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 21, 2016 Category: Hematology Authors: Yan Dai, Jose Sangerman, Mehdi Nouraie, Aidan D. Faller, Patricia Oneal, Angela Rock, Oluwakemi Owoyemi, Xiaomei Niu, Sergei. Nekhai, Dashmeet Maharaj, Shauiying Cui, Robert Taylor, Martin Steinberg, Susan Perrine Tags: Correspondence Source Type: research

Mononucleosis ‐induced pseudo neutropenia
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 20, 2016 Category: Hematology Authors: Michael Loudin, Thomas Deloughery, Joseph Shatzel Tags: Images in Hematology Source Type: research

Hydroxyurea Effectiveness in Children and Adolescents with Sickle Cell Anemia: A Large Retrospective, Population ‐Based Cohort
Abstract The clinical efficacy of hydroxyurea in patients with sickle cell anemia (SCA) has been well established. However, data about its clinical effectiveness in practice is limited. We evaluated the clinical effectiveness of hydroxyurea in a large pediatric population using a retrospective cohort, pre‐post treatment study design to control for disease severity selection bias. The cohort included children with SCA (SS, Sβ0thalassemia) who received care at Children's Healthcare of Atlanta (CHOA) and who initiated hydroxyurea in 2009‐2011. Children on chronic transfusions, or children with inadequate follow up da...
Source: American Journal of Hematology - October 20, 2016 Category: Hematology Authors: Maa ‐Ohui Quarmyne, Wei Dong, Rodney Theodore, Sonia Anand, Vaughn Barry, Olufolake Adisa, Iris D. Buchanan, James Bost, Robert C. Brown, Clinton H. Joiner, Peter A. Lane Tags: Research Article Source Type: research

Clinical Pathways in Chronic lymphocytic Leukemia: Challenges and Solutions
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 19, 2016 Category: Hematology Authors: Chadi Nabhan, Anthony R. Mato, Bruce A. Feinberg Tags: Commentary Source Type: research

Treatment of Central Venous Catheter ‐Associated Deep Venous Thrombosis in Cancer Patients with Rivaroxaban
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 19, 2016 Category: Hematology Authors: Eva S Laube, Simon Mantha, Patrick Samedy, Jonathan Wills, Stephen Harnicar, Gerald A. Soff Tags: Correspondence Source Type: research

Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management
Disease overview:Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in one or more extra‐cutaneous organs. Diagnosis: The major criterion is presence of multifocal clusters of morphologically abnormal MC in the bone marrow. Minor diagnostic criteria include elevated serum tryptase level, abnormal MC expression of CD25 and/or CD2, and presence of KITD816V. Risk stratification: The 2008 World Health Organization (WHO) classification of SM has been shown to be prognostically relevant. Classification of SM patients into indolent (SM), aggressive SM (ASM), SM associated with a clonal no...
Source: American Journal of Hematology - October 19, 2016 Category: Hematology Authors: Animesh Pardanani Tags: CME Information: Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management Source Type: research

2017 Clinical trials update in new treatments of β‐thalassemia
The underlying basis of β‐thalassemia pathology is the diminished β‐globin synthesis leading to α‐globin accumulation and premature apoptotic destruction of erythroblasts, causing oxidative stress‐induced ineffective erythropoiesis, bone marrow hyperplasia, splenomegaly, and increased intestinal iron absorption with progressive iron overload. Better understanding of the molecular mechanisms underlying this disease led to the recognition of new targets with potential therapeutic utility. Agents such as JAK2 inhibitors and TGF‐β ligand traps that reduce the ineffective erythropoiesis process ar...
Source: American Journal of Hematology - October 19, 2016 Category: Hematology Authors: Alexandros Makis, Eleftheria Hatzimichael, Ioannis Papassotiriou, Ersi Voskaridou Tags: Updates in Clinical Trials for Hematological Diseases Source Type: research

Issue Information – Table of Contents
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 19, 2016 Category: Hematology Tags: Issue Information – Table of Contents Source Type: research

Concurrent STAT3, DNMT3A and TET2 mutations in T ‐LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 18, 2016 Category: Hematology Authors: Philipp W. Raess, Michael J. Cascio, Guang Fan, Richard Press, Brian J. Druker, Diana Brewer, Stephen E. Spurgeon Tags: Correspondence Source Type: research

Atypical hemolytic uremic syndrome associated with Capnocytophaga canimorsus
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 13, 2016 Category: Hematology Authors: Kelsey A. Sokol, Rajwanth R. Veluswamy, Brittney S. Zimmerman, Sri Lekha Tummalapalli, Kevin Troy Tags: Images in Hematology Source Type: research

The use of biomarkers to describe plasma ‐, red cell‐ and blood volume from a simple blood test
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - October 12, 2016 Category: Hematology Authors: Louisa M. Lobigs, Pierre ‐Edouard Sottas, Pitre C. Bourdon, Zoran Nikolovski, Mohamed El‐Gingo, Evdokia Varamenti, Peter Peeling, Brian Dawson, Yorck O. Schumacher Tags: Research Article Source Type: research

Refractory Hairy Cell Leukemia ‐Variant
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 10, 2016 Category: Hematology Authors: Zhihong Hu, Yi Sun, Wei Wang, L. Jeffrey Medeiros, Rashmi Kanagal ‐Shamanna Tags: Images in Hematology Source Type: research

Molecular Testing for JAK2, MPL, and CALR in Myeloproliferative Neoplasms
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - October 10, 2016 Category: Hematology Authors: Daniel Xia, Robert P. Hasserjian Tags: Test of the Month Source Type: research

Chronic Granulomatous Disease: Clinical, Functional, Molecular and Genetic Studies. The Israeli Experience with 84 patients
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - October 3, 2016 Category: Hematology Authors: Baruch Wolach, Ronit Gavrieli, Martin de Boer, Karin van Leeuwen, Sivan Berger ‐Achituv, Tal Stauber, Josef Ben Ari, Menachem Rottem, Yechiel Schlesinger, Galia Grisaru‐Soen, Omar Abuzaitoun, Nufar Marcus, Ben Zion Garty, Arnon Broides, Jakov Levy, Po Tags: Research Article Source Type: research

Hereditary Persistence of Fetal Hemoglobin in two patients with KLF1 haploinsufficiency due to 19p13.2 –p13.12/13 deletion
(Source: American Journal of Hematology)
Source: American Journal of Hematology - October 3, 2016 Category: Hematology Authors: Abdelhafid Natiq, Philippe A. Lysy, Nynke Gillemans, Rianne Schaap, Abdelaziz Sefiani, Saaid Amzazi, Siham Chafai El ‐Alaoui, Ileana Cantú, Bella Banjanin, Kirsten van Lom, Cornelis L. Harteveld, Sjaak Philipsen Tags: Correspondence Source Type: research

2017 Clinical trials update: Innovations in hemophilia therapy
A surge in therapeutic clinical trials over recent years is paving the way for transformative treatment options for patients with hemophilia. The introduction of recombinant factor concentrates in the early 1990s facilitated the use of prophylactic replacement as standard care for hemophilia rather than on‐demand treatment. This has revolutionized health outcomes for hemophilia patients, enabling participation in physical activities and reducing debilitating, chronic joint damage. Challenges of prophylactic factor infusion include the frequency of infusions needed to maintain factor levels greater than 1%, patient adhere...
Source: American Journal of Hematology - October 2, 2016 Category: Hematology Authors: Jan Hartmann, Stacy E. Croteau Tags: Updates in Clinical Trials for Hematological Diseases Source Type: research

Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: a distinct acute chest syndrome phenotype
Current definitions of acute chest syndrome (ACS) in sickle cell anemia (SCA) do not account for rapid progression of respiratory compromise. In this two‐center retrospective cohort study, we tested the hypothesis that in children and adults with ACS and respiratory failure (≤24 hours after onset of respiratory symptoms) have a distinct ACS phenotype associated with multiorgan failure when compared to those with ACS that have a more subacute and protracted course. We identified 173 individuals (97 children
Source: American Journal of Hematology - October 2, 2016 Category: Hematology Authors: Shruti Chaturvedi, Djamila L. Ghafuri, Jeffrey Glassberg, Adetola A. Kassim, Mark Rodeghier, Michael R. DeBaun Tags: Research Article Source Type: research

A Randomized and Double ‐Blind Controlled Trial Evaluating the Safety and Efficacy of Rituximab for Warm Auto‐Immune Hemolytic Anemia in Adults (the RAIHA study)
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - October 2, 2016 Category: Hematology Authors: Marc Michel, Louis Terriou, Francoise Roudot ‐Thoraval, Mohamed Hamidou, Mikael Ebbo, Guillaume Le Guenno, Lionel Galicier, Sylvain Audia, Bruno Royer, Anne Sophie Morin, Jean Marie Michot, Arnaud Jaccard, Laurent Frenzel, Mehdi Khellaf, Bertrand Godeau Tags: Research Article Source Type: research

DNMT3A Mutations are Associated with Inferior Overall and Leukemia ‐free Survival in Chronic Myelomonocytic Leukemia
Abstract DNMT3A mutations are seen in ∼5% of patients with chronic myelomonocytic leukemia (CMML) and thus far, have had an indeterminate prognostic impact on survival. We carried out this study to assess the prognostic impact of DNMT3A mutations on a larger informative cohort of CMML patients (n=261). DNMT3A mutations were seen in 6% (n=16); 56% (n=9) male, with a median age of 64 years. Eighty‐one % of DNMT3A mutations were missense, with the Arg882 mutational hot spot accounting for 63% of all changes. Five (31%) patients had an abnormal karyotype whereas concurrent gene mutations (SF3B1/SRSF2/U2AF1‐56%, TET2‐...
Source: American Journal of Hematology - September 30, 2016 Category: Hematology Authors: Mrinal M. Patnaik, Daniela Barraco, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, Ayalew Tefferi Tags: Research Article Source Type: research

Clinical characteristics of Philadelphia positive T ‐cell lymphoid leukemias – (de novo and blast phase CML)
(Source: American Journal of Hematology)
Source: American Journal of Hematology - September 30, 2016 Category: Hematology Authors: Preetesh Jain, Hagop Kantarjian, Elias Jabbour, Rashmi Kanagal ‐Shamanna, Keyur Patel, Sherry Pierce, Guillermo Garcia‐Manero, Gautam Borthakur, Farhad Ravandi, Susan O'Brien, Jorge Cortes Tags: Correspondence Source Type: research

Red Cell Survival and NO Scavenging in Sickle Cell Disease
(Source: American Journal of Hematology)
Source: American Journal of Hematology - September 30, 2016 Category: Hematology Authors: H. Franklin Bunn Tags: Commentary Source Type: research

Reduced Intensity Conditioned Allograft Yields Favorable Survival for Older Adults with B ‐cell Acute Lymphoblastic Leukemia
We examined the effectiveness of reduced intensity conditioning (RIC) hematopoietic cell transplant (HCT) in adults with B‐ALL age 55 years and older and explored prognostic factors associated with long‐term outcomes. Methods: Using CIBMTR registry data, we evaluated 273 patients (median age 61, range 55‐72) with B‐ALL with disease status in CR1 (71%),>CR2 (17%) and Primary Induction Failure (PIF)/Relapse (11%), who underwent RIC HCT between 2001‐2012 using mostly unrelated donor (59%) or HLA‐matched sibling (32%). Among patients with available cytogenetic data, the Philadelphia chromosome (Ph+) was present ...
Source: American Journal of Hematology - September 30, 2016 Category: Hematology Authors: Ashley Rosko, Hai ‐Lin Wang, Marcos de Lima, Brenda Sandmaier, H. Jean Khoury, Andrew Artz, Johnathan Brammer, Christopher Bredeson, Sherif Farag, Mohamed Kharfan‐Dabaja, Hillard M. Lazarus, David I. Marks, Rodrigo Martino Bufarull, Joseph McGuirk, Mo Tags: Research Article Source Type: research

Risk Factors for Infections In Myelofibrosis: Role of Disease Status and Treatment. A multicenter study of 507 patients
Abstract Although infectious complications represent a relevant cause of morbidity and mortality in patients with myelofibrosis (MF), little is known about their incidence, outcome and risk factors. We retrospectively evaluated a cohort of 507 MF patients, diagnosed between 1980 and 2014 in five Italian hematology centers, to define the epidemiology of infections and describe the impact of ruxolitinib (RUX) treatment. Overall, 112 patients (22%) experienced 160 infectious events (grade 3‐4, 45%) for an incidence rate of 3.9% per patient‐year. Infections were mainly bacterial (78%) and involving the respiratory tract (5...
Source: American Journal of Hematology - September 30, 2016 Category: Hematology Authors: Nicola Polverelli, Massimo Breccia, Giulia Benevolo, Bruno Martino, Alessia Tieghi, Roberto Latagliata, Elena Sabattini, Mara Riminucci, Laura Godio, Lucia Catani, Maura Nicolosi, Margherita Perricone, Daria Sollazzo, Gioia Colafigli, Anna Campana, France Tags: Research Article Source Type: research

CD38, BCL ‐2, PD‐1 and PD‐1L expression in nodal peripheral T‐cell lymphoma (PTCL): Possible biomarkers for novel targeted therapies?
(Source: American Journal of Hematology)
Source: American Journal of Hematology - September 30, 2016 Category: Hematology Authors: Francesco Zaja, Valentina Tabanelli, Claudio Agostinelli, Angelica Calleri, Annalisa Chiappella, Marzia Varettoni, Pier Luigi Zinzani, Stefano Volpetti, Elena Sabattini, Renato Fanin, Stefano Aldo Pileri Tags: Correspondence Source Type: research

Erythrocyte adenosine deaminase levels are elevated in Diamond Blackfan anemia but not in the 5q − syndrome
(Source: American Journal of Hematology)
Source: American Journal of Hematology - September 29, 2016 Category: Hematology Authors: Anupama Narla, Natalie L. Davis, Corinne Lavasseur, Carolyn Wong, Bertil Glader Tags: Correspondence Source Type: research

Thiotepa ‐based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia ‐ a survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - September 28, 2016 Category: Hematology Authors: Sandra Eder, Eric Beohou, Myriam Labopin, Jaime Sanz, J ürgen Finke, William Arcese, Reuven Or, Francesca Bonifazi, Mahmoud Aljurf, Gerard Socié, Jakob Passweg, Sebastian Giebel, Mohamad Mohty, Arnon Nagler Tags: Research Article Source Type: research

PET ‐positive lymphadenopathy in CLL – Not always Richter transformation
(Source: American Journal of Hematology)
Source: American Journal of Hematology - September 26, 2016 Category: Hematology Authors: Naveen Pemmaraju, Preetesh Jain, L. Jeffrey Medeiros, Jeffrey L. Jorgenson, Nitin Jain, Jason Willis, Dimitrios P. Kontoyiannis, Zeev Estrov, William Wierda Tags: Images in Hematology Source Type: research

Buparlisib, a PI3K Inhibitor, Demonstrates Acceptable Tolerability and Preliminary Activity in a Phase I Trial of Patients with Advanced Leukemias
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - September 26, 2016 Category: Hematology Authors: Brittany Knick Ragon, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi, Jorge Cortes, Gautam Borthakur, LaKiesha DeBose, Zhihong Zeng, Heather Schneider, Naveen Pemmaraju, Guillermo Garcia ‐Manero, Steven Kornblau, William Wierda, Jan Burger, Courtney D. Tags: Research Article Source Type: research

Fludarabine and Cytarabine versus High ‐dose Cytarabine in Consolidation Treatment of t(8; 21) Acute Myeloid Leukemia: a prospective, randomized study
This article is protected by copyright. All rights reserved. (Source: American Journal of Hematology)
Source: American Journal of Hematology - September 26, 2016 Category: Hematology Authors: Ruiqi Li, Xiaoxia Hu, Libing Wang, Hui Cheng, Shuqing Lv, Weiping Zhang, Jianmin Wang, Jianmin Yang, Xianmin Song Tags: Research Article Source Type: research

Circulating lymphoma cells in intravascular large B ‐cell lymphoma
(Source: American Journal of Hematology)
Source: American Journal of Hematology - September 23, 2016 Category: Hematology Authors: Nicholas J. Fordham, Simon O'Connor, Simon Stern, Veselka Nikolova, Barbara J. Bain Tags: Morphology Update Source Type: research

Reply to McCulley et al., reports to FDA of fatal anaphylaxis associated with intravenous iron products
(Source: American Journal of Hematology)
Source: American Journal of Hematology - September 22, 2016 Category: Hematology Authors: Michael Auerbach, John Adamson Tags: Correspondence Source Type: research

Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid ‐directed monoclonal antibody
(Source: American Journal of Hematology)
Source: American Journal of Hematology - September 21, 2016 Category: Hematology Authors: Morie A. Gertz, Heather J. Landau, Brendan M. Weiss Tags: Correspondence Source Type: research